DoD Seeks Host-Directed Therapeutics to Counter Emerging Biological Threats
A New Direction: Host-Directed, Not Pathogen-Specific Unlike traditional antivirals or antibiotics, host-directed therapeutics (HDTs) focus on modulating the patient’s immune response rather than targeting a specific pathogen. This “threat-agnostic” approach is especially promising in an era marked by evolving biological agents and unpredictable infectious threats. The DoD is particularly interested in repurposed FDA-approved therapeutics or […]
DoD Seeks Host-Directed Therapeutics to Counter Emerging Biological Threats Read More »